Effect of Enalpril on acute liver injury induced by CCl4 in rats and its anti-oxidative function
Jian-Ping Zhang,Hong-Shan Wei,Shun-Ai Liu,Jing-Jing Guo,Qian-Ying Zhang,Xiao-Hong Shi,Si-Ping Zhang,Zhi-Ying Liu,Xin Feng,Hong-Buo Lv
DOI: https://doi.org/10.11569/wcjd.v12.i11.2638
2004-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the effect of Enalpril on acute liver injury induced by carbon tetrachloride (CCl4) in rats and its anti-oxidative function. METHODS: Fifty normal male SD rats were randomly divided into five groups (10 rats/group): Enalpril interventional groups A, B, and C (10, 5, and 2.5 mg/kg, respectively), injury-model group, and control group. Rats in interventional and model groups were given hypodermic CCl4 (diluted with an equal volume of olive oil). Rats in control group received normal saline injection. Rats with liver injury induced by CCl4 were then treated with Enalpril (10, 5, 2.5; ig). The activities of serum aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and total bile acid (TBA) were detected using full automatic biochemical analyzer. Superoxide dismutase (SOD), xanthine oxidase (XOD), glutathione perioxidase (GSH-PX), and malondialdehyde (MDA) were determined using colorimetric method. RESULTS: Enalpril significantly reduced serum ALT (685 ± 63, 1 241 ± 168, 1 705 ± 83, 2 302 ± 174 nkat/L vs 3 531 ± 776 nkat/L in control, A, B, C versus model group respectively; P <0.01), AST (1 240 ± 158, 2 430 ± 386 nkaVL vs, 3 372 ± 138 nkat/L in control, A versus model group; P <0.01, P <0.05 respectively), ALP (2 659 ± 248, 2 567 ± 159 nkat/L vs 3 609 ± 346 nkat/L in control, A versus model group; P <0.01) and TBA (8.48 ± 0.49, 16.35 ± 5.43, 16.92 ± 2.68 μmol/L vs 24.16 ± 9.27 μmol/L in control, A, B versus model group; P <0.01, P <0.05, P <0.05 respectively) in acute liver injury induced by CCl4. The level of XOD in model group was significantly higher than that in control, A, B and C groups (1 042 ± 188 nkat/L vs 571 ± 28, 724 ± 18, 821 ± 28, 868 ± 58 nkat/L; P <0.01). SOD level in model group was significantly higher than that in control and A group (8 579 ± 861 nkat/L vs 6 006 ± 639, 7 135 ± 1 560 nkat/L; P <0.01, P <0.05). MDA level in interventional group was obviously lower than that in model group and GSH-PX level was obviously higher than that in model group. CONCLUSION: Enalpril has protective effects for rats with acute hepatic injury induced by carbon tetrachloride and the mechanism closely relates to its anti-oxidative function.